8X8 INC /DE/ financials

SEC pipeline catching up: most recent reported quarter (2026-03-31) isn't incorporated yet — this page is anchored to 2025-12-31 (Q3 2026 · 10-Q). New filings land within a few weekday pipeline runs.
EGHT CIK 0001023731

Source: EDGAR filings · Built 2026-06-02T02:53:44Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 61.15M 76.33M 45.80M 30.53M -20.57M -130.05M
EBITDA 35.29M -803.00K -29.49M -112.04M -107.15M -131.42M
Working Capital 34.62M 75.25M 43.24M 84.09M 155.16M 153.74M
Net Debt 322.21M 361.37M 225.48M 446.25M 291.30M 252.47M
Gross Margin 67.86% 69.14% 67.54% 61.21% 15.71% 14.31%
Operating Margin 2.12% -3.79% -8.91% -24.16% -27.45% -35.81%
Net Margin -3.81% -9.28% -9.83% -27.48% -31.10% -38.63%
Return on Equity (ROE) -22.27% -66.29% -73.21% -96.17% -103.17% -90.37%
Return on Assets (ROA) -3.98% -8.94% -8.69% -19.27% -24.41% -24.60%
Current Ratio 1.20× 1.44× 1.19× 1.44× 2.28× 2.25×
Debt-to-Equity 3.36× 4.68× 3.37× 2.95× 2.52× 2.04×
Effective Tax Rate -13.09% -5.70% -3.99% 0.22% -0.51% -0.48%
Cash Conversion Ratio -2.34× -1.17× -0.67× -0.20× 0.08× 0.54×
Accruals Ratio -0.13× -0.19× -0.14× -0.23× -0.22× -0.11×
SBC % of Revenue 5.59% 8.50% 12.04% 20.89% 20.22% 15.88%
CapEx Coverage 26.47× 29.81× 16.31× 8.35× -2.16× -2.60×
Free Cash Flow Per Share $0.47 $0.63 $0.39 $0.27 $-0.19 $-1.30

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/FCF 4.24× 4.28× 10.56× 46.75×
FCF Yield 23.57% 23.34% 9.47% 2.14%
EV / EBITDA 16.74×
P/S 0.38× 0.46× 0.64× 2.33× 6.65× 3.20×
P/B 2.20× 3.32× 4.79× 8.14× 22.06× 7.50×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 715.07M 728.71M 743.94M 638.13M 532.34M 446.24M
Cost of Goods and Services Sold 229.80M 224.91M 241.47M 247.56M
Gross Profit 485.27M 503.80M 502.46M 390.57M 83.61M 63.86M
Research and Development Expense 123.21M 136.22M 142.49M 112.39M 92.03M 77.79M
Operating Expenses 470.08M 531.40M 568.75M 544.71M 678.49M 606.06M
Operating Income (Loss) 15.19M -27.60M -66.29M -154.14M -146.15M -159.82M
Income Tax Expense (Benefit) 3.15M 3.64M 2.81M -387.00K 843.00K 832.00K
Net Income (Loss) Attributable to Parent -27.21M -67.59M -73.14M -175.38M -165.59M -172.37M
Earnings Per Share, Basic $-0.21 $-0.56 $-0.63 $-1.55 $-1.57 $-1.72
Weighted Average Number of Shares Outstanding, Basic 129.77M 121.11M 115.96M 113.35M 105.70M 100.00M
Earnings Per Share, Diluted $-0.21 $-0.56 $-0.63 $-1.55 $-1.57 $-1.72
Weighted Average Number of Shares Outstanding, Diluted 129.77M 121.11M 115.96M 113.35M 105.70M 100.00M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 88.05M 116.26M 111.40M 91.20M 112.53M 137.39M
Assets, Current 203.87M 247.84M 273.12M 275.62M 276.53M 277.16M
Assets 683.18M 755.98M 841.81M 910.27M 678.41M 700.64M
Long-term Debt 349.96M 409.69M
Liabilities, Current 169.24M 172.58M 229.89M 191.53M 121.38M 123.42M
Long-term Debt, Excluding Current Maturities 338.37M 409.69M 447.45M 308.44M 291.54M
Liabilities 560.97M 654.02M 741.90M 727.90M 517.90M 509.91M
Stockholders' Equity Attributable to Parent 122.20M 101.96M 99.91M 182.37M 160.50M 190.73M
Common Stock, Shares, Outstanding 134.35M 125.19M 114.66M 117.86M 109.13M 103.18M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 63.55M 78.98M 48.79M 34.68M -14.07M -93.91M
Payments to Acquire Property, Plant, and Equipment 2.40M 2.65M 2.99M 4.14M 6.43M 35.83M
Net Cash Provided by (Used in) Investing Activities -16.42M 8.55M 6.05M -159.98M -36.32M -106.29M
Payments for Repurchase of Common Stock 0 0 60.21M 44.98M 0 0
Net Cash Provided by (Used in) Financing Activities -75.11M -83.41M -37.78M 105.42M 13.19M 72.09M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (EGHT CIK 0001023731), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ORMP

ORAMED PHARMACEUTICALS INC.

ABG

ASBURY AUTOMOTIVE GROUP, INC.

FDMT

4D Molecular Therapeutics, Inc.